PE20001487A1 - 1,2,3,4,5,6-hexahidro-2,6-metano-3-benzazocin-10-oles sustituidos con n-(5-fenil-tetrahidrofuranil) metilo y n-(6-fenil-tetrahidropiranil) metilo; procedimientos para prepararlos y su empleo como composiciones farmaceuticas - Google Patents

1,2,3,4,5,6-hexahidro-2,6-metano-3-benzazocin-10-oles sustituidos con n-(5-fenil-tetrahidrofuranil) metilo y n-(6-fenil-tetrahidropiranil) metilo; procedimientos para prepararlos y su empleo como composiciones farmaceuticas

Info

Publication number
PE20001487A1
PE20001487A1 PE2000000132A PE0001322000A PE20001487A1 PE 20001487 A1 PE20001487 A1 PE 20001487A1 PE 2000000132 A PE2000000132 A PE 2000000132A PE 0001322000 A PE0001322000 A PE 0001322000A PE 20001487 A1 PE20001487 A1 PE 20001487A1
Authority
PE
Peru
Prior art keywords
methyl
phenyl
benzazocin
oles
hexahydro
Prior art date
Application number
PE2000000132A
Other languages
English (en)
Inventor
Hans Briem
Matthias Grauert
Adrian Carter
Palluk Rainer
Matthias Hoffmann
Thomas Weiser
Wolf-Dietrich Bechtel
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of PE20001487A1 publication Critical patent/PE20001487A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

SE REFIERE A 1,2,3,4,5,6-HEXAHIDRO-2,6-DIMETANO-3-BENZAZOCIN-10-OLES DE FORMULA I, DONDE R1, R2, R4 Y R5 SON H, METILO, F; n ES1-2; R3 ES H, F, Cl, Br, METILO, ETILO, OH, METOXI; R6 ES H, METILO, ETILO. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION CARACTERIZADO PORQUE UN DERIVADO DE NOR-BENZOMORFANO REACCIONA CON UN DERIVADO DE TETRAHIDROFURANO, HEXAHIDROPIRANO Y EL PRODUCTO FINAL SE PURIFICA, SE AISLA. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE 0,001% A 5% EN PESO DEL COMPUESTO. EL COMPUESTO ES UN BLOQUEADOR DE LOS CANALES DE SODIO DEPENDIENTE DE VOLTAJE Y PUEDE SER UTIL PARA EL TRATAMIENTO DE TRASTORNOS FUNCIONALES CAUSADOS POR SOBREESTIMULACION, ARRITMIAS, ESPASMOS, ISQUEMIA CARDIACA, CEREBRAL, DOLOR, TRASTORNOS NEURODEGENERATIVOS, EPILEPSIA, HIPOGLUCEMIA, HIPOXIA, INOXIA, TRAUMA CEREBRAL, EDEMA CEREBRAL
PE2000000132A 1999-02-23 2000-02-21 1,2,3,4,5,6-hexahidro-2,6-metano-3-benzazocin-10-oles sustituidos con n-(5-fenil-tetrahidrofuranil) metilo y n-(6-fenil-tetrahidropiranil) metilo; procedimientos para prepararlos y su empleo como composiciones farmaceuticas PE20001487A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19907874A DE19907874A1 (de) 1999-02-23 1999-02-23 N-(5-Phenyl-tetrahydrofuranyl)methyl- und N-(6-Phenyl-tetrahydropyranyl)methyl substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocin-10-ole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
PE20001487A1 true PE20001487A1 (es) 2001-01-18

Family

ID=7898638

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000132A PE20001487A1 (es) 1999-02-23 2000-02-21 1,2,3,4,5,6-hexahidro-2,6-metano-3-benzazocin-10-oles sustituidos con n-(5-fenil-tetrahidrofuranil) metilo y n-(6-fenil-tetrahidropiranil) metilo; procedimientos para prepararlos y su empleo como composiciones farmaceuticas

Country Status (14)

Country Link
EP (1) EP1157020B1 (es)
JP (1) JP2002537393A (es)
AR (1) AR022718A1 (es)
AT (1) ATE224890T1 (es)
AU (1) AU2910900A (es)
CA (1) CA2362697C (es)
CO (1) CO5170499A1 (es)
DE (2) DE19907874A1 (es)
DK (1) DK1157020T3 (es)
ES (1) ES2183786T3 (es)
PE (1) PE20001487A1 (es)
PT (1) PT1157020E (es)
UY (1) UY26022A1 (es)
WO (1) WO2000050421A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19957156A1 (de) * 1999-11-27 2001-05-31 Boehringer Ingelheim Pharma Substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocine und ihre Verwendung als Arzneimittel
US6355652B1 (en) 1999-11-27 2002-03-12 Boehringer Ingelheim Pharma Kg Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositions
US20030045449A1 (en) * 2001-08-15 2003-03-06 Pfizer, Inc. Pharmaceutical combinations for the treatment of neurodegenerative diseases
DE10204276A1 (de) * 2002-02-02 2003-08-07 Boehringer Ingelheim Pharma N-Allyloxyethyl-1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocine und ihre Verwendung als Arzneimittel
US6683089B2 (en) 2002-02-02 2004-01-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg N-allyoxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-ols
WO2009063061A2 (en) * 2007-11-16 2009-05-22 Boehringer Ingelheim International Gmbh Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
JP7289119B2 (ja) * 2019-02-15 2023-06-09 国立大学法人千葉大学 光学活性置換テトラヒドロフラン誘導体を合成する方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1575009A (en) * 1976-06-21 1980-09-17 Acf Chemiefarma Nv 6,7-benzomorphan derivatives
AU524600B2 (en) * 1976-09-22 1982-09-23 Sterling Drug Inc. 2,6-methano-3-benzazocines
JPS5513253A (en) * 1978-07-15 1980-01-30 Res Inst For Prod Dev Cis-3-aralkyl substituted-8-benzoylthio-6,11-dimethyl-2,6- methano-1,2,3,4,5,6-hexahydro-3-benzazocine or its acid addition salt
DE3839659A1 (de) * 1988-11-24 1990-05-31 Boehringer Ingelheim Kg Verwendung von benzomorphanen zur zytoprotektion

Also Published As

Publication number Publication date
ES2183786T3 (es) 2003-04-01
DE19907874A1 (de) 2000-08-24
DK1157020T3 (da) 2003-01-27
ATE224890T1 (de) 2002-10-15
WO2000050421A1 (de) 2000-08-31
JP2002537393A (ja) 2002-11-05
CA2362697C (en) 2008-04-22
AU2910900A (en) 2000-09-14
EP1157020A1 (de) 2001-11-28
AR022718A1 (es) 2002-09-04
CO5170499A1 (es) 2002-06-27
DE50000560D1 (de) 2002-10-31
EP1157020B1 (de) 2002-09-25
PT1157020E (pt) 2003-01-31
UY26022A1 (es) 2000-09-29
CA2362697A1 (en) 2000-08-31

Similar Documents

Publication Publication Date Title
TR200000837A2 (tr) Anti-kanser bileşimleri hazırlamak için işlem ve ara maddeler.
EA199901014A1 (ru) C-4"-замещенные макролидные производные
EA200100553A1 (ru) Замещенные бициклические производные, полезные в качестве противораковых агентов
AR031828A2 (es) Procedimientos para la preparacion de compuestos espiro-azabiciclicos utiles en terapia
EA200500174A1 (ru) Новые производные бензимидазола, полезные в качестве антипролиферативных агентов
KR950017957A (ko) 3, 4, 4-삼치환-피페리디닐-n-알킬카르복실레이트의 제법 및 중간체
FR2714378B1 (fr) Dérivés de l'indol-2-one substitués en 3 par un groupe azoté, leur préparation, les compositions pharmaceutiques en contenant.
FI954130A (fi) Heterosykliset yhdisteet ja niiden valmistus ja käyttö
UY27368A1 (es) Nuevos compuestos
EA200500088A1 (ru) Трициклические модуляторы ядерного рецептора стероидного гормона
PL315636A1 (en) Cosmetic or pharmaceutic compositions containing magnipherine or its derivatives
MA27867A1 (fr) Nouveaux derives de 2h-pyridazine-3-one, compositions pharmaceutiques contenant ces derives et procede de preparation de l'ingredient actif.
DE3246503A1 (de) Derivate der cis, endo-2-azabicyclo-(5.3.0)-decan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung
ES2084339T3 (es) Tetrahidropiridinas e hidroxipiperidinas sustituidas utiles como agentes para el sistema nervioso central.
ES2079075T3 (es) Compuestos heterociclicos y su preparacion y uso.
CA2386799A1 (en) Fused cycloheptane and fused azacycloheptane compounds and their as integrin receptor antagonists
RU94046107A (ru) Замещенные производные 2 бета - морфолинандростана, способ их получения, фармакомпозиция, содержащая их
GEP20012389B (en) Benzoxazinone Dopamine D4 Receptor Antagonists, Pharmaceutical Composition Containing the Same and Method for Treatment of Psychosis or Schizophrenia
PE20001487A1 (es) 1,2,3,4,5,6-hexahidro-2,6-metano-3-benzazocin-10-oles sustituidos con n-(5-fenil-tetrahidrofuranil) metilo y n-(6-fenil-tetrahidropiranil) metilo; procedimientos para prepararlos y su empleo como composiciones farmaceuticas
KR900016167A (ko) 아릴-치환된 로다닌 유도체
BR9503572A (pt) Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença
ES2029801T3 (es) Procedimiento para preparar acidos tetrahidro-3-piridina-carboxilicos sustituidos y esteres y amidas de los mismos con actividad colinergica.
CA2314154A1 (en) Azepine or larger medium ring derivatives and their use as pharmaceuticals
PE122899A1 (es) 1,2,3,4,5,6-hexahidro-2,6-metano-3-benzazocin-10-oles sustituidos y procedimientos para su preparacion
NO20014240D0 (no) C16-umettede FP-selektive prostaglandinanaloger

Legal Events

Date Code Title Description
FD Application declared void or lapsed